JEMDSA

Medpharm Publications · South Africa · Est. 2004

ISSN1608-9677eISSN2220-1009

✓ WOS ESCI✓ DOAJ✓ Open Access

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Source: Clarivate Journal Citation Reports.

H-Indexi

Total Worksi

443

Total Citationsi

2,956

2yr Mean Citednessi

0.38

Open Impact Factor alternative

Aims & Scope

Subject areas: Medicine. Topics: endocrinology, metabolism, diabetes

General Information

Country / RegionSouth Africa

Primary LanguageEnglish

1st Year Published2004

Annual Volume~ 13 articles / year

StatusActive (last: 2026)

Total Publications443

Publisher OrgTaylor & Francis

OA Since2003

Visit Journal Website

Submission Info

Peer ReviewDouble anonymous peer review

OA LicenseCC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

8/11 · 73%

✅

Do you know the journal / publisher?

Medpharm Publications

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1608-9677 / 2220-1009

✅

Indexed in a trusted database?

WoS, DOAJ

✅

Peer review process documented?

Double anonymous peer review

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

103

2019

2020

118

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

Subject Classification

Web of Science Categories

Endocrinology & Metabolism

Research Topics (OpenAlex)

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchDiabetes Management and EducationChronic Disease Management StrategiesBone health and osteoporosis researchDiabetes and associated disordersHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Treatment and ManagementDiabetic Foot Ulcer Assessment and ManagementThyroid Disorders and Treatments

Frequently asked questions about JEMDSA

Is JEMDSA a predatory journal?

PubScope has no integrity flags on record for JEMDSA: it is indexed in Web of Science, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of JEMDSA?

JEMDSA is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 0.38.

Is JEMDSA indexed in Scopus and Web of Science?

JEMDSA is indexed in Web of Science, DOAJ.

What is the aims and scope of JEMDSA?